Palisade Bio

Price & Volume

Stats

Open	$1.83
Previous Close	$1.85
Day Range	$1.80-$1.83
52W Range	$0.53-$2.64
Market Cap	$283.4M
Shares Short	25M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$2.07

News

Yahoo Finance • 3 months ago

Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development

Yahoo Finance • 3 months ago

Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference

Yahoo Finance • 4 months ago

Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations

Yahoo Finance • 4 months ago

Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn’s Disease (FSCD)

About

CEO	Mr. J. D. Finley
CFO	Mr. J. D. Finley
Address	7750 El Camino Real, Carlsbad, CA, United States, 92009
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	8